BIIB vs VERO · P/E 21, rev $9.89B vs rev $64.8M
Biogen Inc (BIIB) versus Venus Concept Inc (VERO) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Venus Concept Inc (VERO) is a medical devices company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported VERO revenue for 2024-12-31 was $64.8M. Net income was -$47.0M. Revenue was down 15.1% from 2023-12-31 to 2024-12-31. VERO currently screens at market cap $578.2K.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. VERO currently screens at market cap $578.2K.
Not investment advice. Open the BIIB and VERO stock pages for the full models.
Not investment advice.